Splice-disrupt genomic variants in prostate cancer.
Ibrahim O AlanaziSalman F AlameryEsmaeil EbrahimieManijeh Mohammadi-DehcheshmehPublished in: Molecular biology reports (2022)
This is the first study that profiles the splice-disrupt genomic variants and their target genes in different types of prostate cancer. Unravelling alternative splicing opens a new avenue towards the establishment of new diagnostic and prognostic markers for prostate cancer progression and metastasis.